Therefore, this study aims to provide an overview of EGFR mutations in NSCLC, emphasizing their prevalence and the distinction between common and rare mutations while highlighting the significance of targeted therapies over chemotherapy. Here, EGFR is linked to non-small cell lung carcinoma.